Mpox Guideline Development Group biographies

Overview

For the development of the Clinical management and infection prevention and control for mpox, a Guideline Development Group (GDG) comprising individuals with broad expertise spanning multiple specialties and all regions was convened. This group includes patient panel members.

The technical unit collected and managed declarations of interests (DOIs) which were declared upon becoming a group member and at each meeting.

WHO wishes to acknowledge all the experts that contributed to the GDG and to thank them for their commitment and support to achieve the evidence-based recommendations for care of patients with mpox.